Expert opinion on clinical presentation, diagnosis, and treatment of infantile-onset Pompe disease: a Delphi study in Türkiye

dc.contributor.authorOzsaydi Aktasoglu, Ekin
dc.contributor.authorInci, Asli
dc.contributor.authorOktem, Ridvan Murat
dc.contributor.authorBiberoglu, Gursel
dc.contributor.authorOkur, Ilyas
dc.contributor.authorEzgu, Fatih Suheyl
dc.contributor.authorTumer, Leyla
dc.date.accessioned2026-08-12T17:11:05Z
dc.date.issued2025
dc.departmentFırat Üniversitesi
dc.description.abstractBackground/aim: Pompe disease (acid maltase deficiency, glycogen storage disease type II, OMIM #606800) is an autosomal recessive disorder characterized by lysosomal acid-alpha-glucosidase deficiency. The infantile-onset type of the disease is mainly characterized by cardiomegaly, hypotonia, and a high mortality rate. This study aimed to create a national consensus about infantile-onset Pompe disease (IOPD) to raise awareness among clinicians and standardize diagnosis and treatment approaches in T & uuml;rkiye. Materials and methods: The Gazi University Division of Metabolic Diseases and Nutrition developed this expert opinion consensus and expanded it to include metabolism specialists across T & uuml;rkiye. A systematic literature review was performed, and the Delphi method was used to evaluate the results. Results: Seventeen conclusive questions were produced about clinical presentation, diagnosis, and treatment, and 14 reached a consensus. Consensus was reached that general hypotonia is one of the most important findings, and agreement was also achieved on the starting dose of treatment for presymptomatic patients. The contributors agreed that gene therapy is a good treatment option for IOPD in the future. Conclusion: The topics related to this consensus will help physicians in T & uuml;rkiye and elsewhere with high incidence rates of IOPD, especially regarding diagnosis and treatment decisions.
dc.identifier.doi10.55730/1300-0144.6005
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.issue3
dc.identifier.orcid0000-0001-7256-0750
dc.identifier.orcid0000-0001-7146-0248
dc.identifier.orcid0000-0002-7527-2620
dc.identifier.orcid0000-0001-9076-1388
dc.identifier.orcid0000-0002-9783-1016
dc.identifier.orcid0000-0002-3735-7439
dc.identifier.pmid40686712
dc.identifier.scopus2-s2.0-105009223930
dc.identifier.scopusqualityQ2
dc.identifier.trdizinid1334058
dc.identifier.urihttps://doi.org/10.55730/1300-0144.6005
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1334058
dc.identifier.urihttps://hdl.handle.net/11508/51018
dc.identifier.volume55
dc.identifier.wosWOS:001528126700006
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTubitak Scientific & Technological Research Council Turkey
dc.relation.ispartofTurkish Journal of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectAcid maltase deficiency
dc.subjectDelphi study
dc.subjectexpert opinion
dc.subjectinfantile-onset Pompe disease
dc.subjectTurkish consensus
dc.titleExpert opinion on clinical presentation, diagnosis, and treatment of infantile-onset Pompe disease: a Delphi study in Türkiye
dc.typeArticle

Dosyalar